- Home
- MIAX vs AAPG Comparison
MIAX vs AAPG Comparison
Compare MIAX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIAX
- AAPG
- Stock Information
- Founded
- MIAX 2007
- AAPG 2009
- Country
- MIAX United States
- AAPG China
- Employees
- MIAX N/A
- AAPG N/A
- Industry
- MIAX Investment Bankers/Brokers/Service
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- MIAX Finance
- AAPG Health Care
- Exchange
- MIAX Nasdaq
- AAPG Nasdaq
- Market Cap
- MIAX 3.6B
- AAPG 3.6B
- IPO Year
- MIAX 2025
- AAPG 2025
- Fundamental
- Price
- MIAX $43.21
- AAPG $33.50
- Analyst Decision
- MIAX Buy
- AAPG Buy
- Analyst Count
- MIAX 6
- AAPG 1
- Target Price
- MIAX $40.60
- AAPG N/A
- AVG Volume (30 Days)
- MIAX 518.1K
- AAPG 7.7K
- Earning Date
- MIAX 11-05-2025
- AAPG 11-19-2025
- Dividend Yield
- MIAX N/A
- AAPG N/A
- EPS Growth
- MIAX N/A
- AAPG N/A
- EPS
- MIAX 0.02
- AAPG N/A
- Revenue
- MIAX $1,255,413,000.00
- AAPG $54,524,554.00
- Revenue This Year
- MIAX N/A
- AAPG N/A
- Revenue Next Year
- MIAX $14.97
- AAPG $368.64
- P/E Ratio
- MIAX $2,080.00
- AAPG N/A
- Revenue Growth
- MIAX 19.63
- AAPG N/A
- 52 Week Low
- MIAX $28.63
- AAPG $16.50
- 52 Week High
- MIAX $45.63
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- MIAX N/A
- AAPG 35.64
- Support Level
- MIAX N/A
- AAPG $33.12
- Resistance Level
- MIAX N/A
- AAPG $35.07
- Average True Range (ATR)
- MIAX 0.00
- AAPG 1.05
- MACD
- MIAX 0.00
- AAPG -0.16
- Stochastic Oscillator
- MIAX 0.00
- AAPG 8.96
About MIAX Miami International Holdings Inc. Common Stock
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.